NO20030021L - Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV - Google Patents
Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IVInfo
- Publication number
- NO20030021L NO20030021L NO20030021A NO20030021A NO20030021L NO 20030021 L NO20030021 L NO 20030021L NO 20030021 A NO20030021 A NO 20030021A NO 20030021 A NO20030021 A NO 20030021A NO 20030021 L NO20030021 L NO 20030021L
- Authority
- NO
- Norway
- Prior art keywords
- dpp
- inhibitors
- heterocyclic compounds
- enzyme dpp
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Abstract
Foreliggende oppfinnelse vedrører terapeutisk aktive og selektive inhibitorer for enzymet DPP-IV, farmasøytiske preparater Som omfatter forbindelsene, og anvendelsen av slike forbindelser til fremstillingen av medikamenter for behandling av sykdommer som er forbundet med proteiner som er gjenstand for inaktivering ved hjelp av DPP- IV, slik som sukkersyke av type 2 og fedme, samt fremgangsmåter for behandling av sykdommer som er forbundet med proteiner som er gjenstand for inaktivering ved hjelp av DPP-IV, slik som sukkersyke av type 2 og fedme.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200001040 | 2000-07-04 | ||
PCT/DK2001/000467 WO2002002560A2 (en) | 2000-07-04 | 2001-07-04 | Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030021D0 NO20030021D0 (no) | 2003-01-03 |
NO20030021L true NO20030021L (no) | 2003-03-03 |
Family
ID=8159598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030021A NO20030021L (no) | 2000-07-04 | 2003-01-03 | Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1561752A1 (no) |
KR (1) | KR20030014394A (no) |
CN (1) | CN1440288A (no) |
AT (1) | ATE299024T1 (no) |
BR (1) | BR0112123A (no) |
CA (1) | CA2411864A1 (no) |
CZ (1) | CZ200319A3 (no) |
DE (1) | DE60111849T2 (no) |
ES (1) | ES2244634T3 (no) |
IL (1) | IL153182A0 (no) |
NO (1) | NO20030021L (no) |
RU (1) | RU2003103103A (no) |
ZA (1) | ZA200209714B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ549716A (en) * | 2004-03-15 | 2010-04-30 | Takeda Pharmaceutical | Pyrimidin-dione derivatives as dipeptidyl peptidase inhibitors |
ATE553077T1 (de) * | 2004-07-23 | 2012-04-15 | Nuada Llc | Peptidaseinhibitoren |
CN102276627B (zh) * | 2010-04-29 | 2013-07-31 | 山东轩竹医药科技有限公司 | 吡啶并杂环衍生物 |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
CN103509023B (zh) * | 2012-06-20 | 2014-08-27 | 成都苑东药业有限公司 | 黄嘌呤衍生物 |
JP6360149B2 (ja) | 2013-03-15 | 2018-07-18 | ハイドラ バイオサイエンシズ インコーポレイテッドHydra Biosciences,Inc. | 置換キサンチンおよびその使用方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2205815A1 (de) * | 1972-02-08 | 1973-08-16 | Hoechst Ag | Piperazinderivate und verfahren zu ihrer herstellung |
GB9020959D0 (en) * | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
-
2001
- 2001-07-04 IL IL15318201A patent/IL153182A0/xx unknown
- 2001-07-04 AT AT01947211T patent/ATE299024T1/de not_active IP Right Cessation
- 2001-07-04 EP EP05008243A patent/EP1561752A1/en not_active Withdrawn
- 2001-07-04 RU RU2003103103/04A patent/RU2003103103A/ru not_active Application Discontinuation
- 2001-07-04 BR BR0112123-5A patent/BR0112123A/pt not_active IP Right Cessation
- 2001-07-04 CN CN01812097A patent/CN1440288A/zh active Pending
- 2001-07-04 KR KR1020027017726A patent/KR20030014394A/ko not_active Application Discontinuation
- 2001-07-04 CA CA002411864A patent/CA2411864A1/en not_active Abandoned
- 2001-07-04 ES ES01947211T patent/ES2244634T3/es not_active Expired - Lifetime
- 2001-07-04 CZ CZ200319A patent/CZ200319A3/cs unknown
- 2001-07-04 DE DE60111849T patent/DE60111849T2/de not_active Expired - Fee Related
-
2002
- 2002-11-29 ZA ZA200209714A patent/ZA200209714B/xx unknown
-
2003
- 2003-01-03 NO NO20030021A patent/NO20030021L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP1561752A1 (en) | 2005-08-10 |
KR20030014394A (ko) | 2003-02-17 |
IL153182A0 (en) | 2003-06-24 |
DE60111849T2 (de) | 2006-06-08 |
CN1440288A (zh) | 2003-09-03 |
ATE299024T1 (de) | 2005-07-15 |
RU2003103103A (ru) | 2004-08-20 |
CZ200319A3 (cs) | 2003-05-14 |
NO20030021D0 (no) | 2003-01-03 |
BR0112123A (pt) | 2003-05-06 |
ZA200209714B (en) | 2003-08-19 |
DE60111849D1 (de) | 2005-08-11 |
ES2244634T3 (es) | 2005-12-16 |
CA2411864A1 (en) | 2002-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02012272A (es) | Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv. | |
WO2004033455A3 (en) | Hemisuccinate salts of heterocyclic dpp-iv inhibitors | |
DE60225556D1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
WO2003024965A3 (en) | Heterocyclic compounds that are inhibitors of the enzyme dpp-iv | |
ECSP055783A (es) | Derivados de fenilalanina como inhibidores de dipeptidilpeptidasa para el tratamiento o prevención de diabetes | |
NO20051966L (no) | Nye pyrimidinamidderivater og anvendelse derav | |
BR0009167A (pt) | Inibidores de enzima impdh | |
EP1841426A4 (en) | TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
ECSP055732A (es) | Inhibidores de la beta-amino heterocíclico dipeptidil peptidasa para el tratamiento o prevención de diabetes | |
ATE408601T1 (de) | Fredericamycin-derivate | |
NO2007010I1 (no) | Sitagliptin, eventuelt i form av et farmasoytisk akseptabelt salt | |
TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
DE60330485D1 (de) | Zur behandlung von diabetes | |
GB0222495D0 (en) | Compounds | |
NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
EA200401471A1 (ru) | Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов | |
TW200517389A (en) | Biaryloxymethylarenecarboxylic acids | |
ATE384058T1 (de) | Thiazolderivate | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
NO20043792L (no) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
AU2003260436A1 (en) | Pyrimidine compounds | |
NO20030021D0 (no) | Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV | |
WO2004056306A3 (de) | Verwendung von l-dopa, seiner derivate und diese verbindungen enthaltender arzneimittel zur prophylaxe psychotischer erkrankungen | |
WO2002023784A3 (en) | Cysteine protease inhibitors |